Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label phase II study - Raghu,G.; Johnson,W.C.; Lockhart,D.; Mageto,Y. (Am J Respir Crit Care Med, 1999)